Log in
Enquire now

List of SBIR/STTR awards granted to MAKScientific LLC

List of SBIR/STTR awards granted to MAKScientific LLC
List of SBIR/STTR awards granted to Airak, Inc.
List of SBIR/STTR awards granted to INNOVATIVE ELEMENTS, LLC
List of SBIR/STTR awards granted to AvaWatz Company
List of companies in Exelon Corporation's investment portfolio
List of Kuhn North America, Inc. patents
where
SBIR/STTR Award Recipient
is
‌
MAKScientific LLC
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
MAKScientific LLC STTR Phase I Award, September 2019

A STTR Phase I contract was awarded to MAKScientific LLC in September, 2019 for $224,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
MAKScientific LLC
National Institutes of Health
National Institutes of Health
STTR
1R41DK115303-01A1
Phase I
224,999
September 1, 2019
sbir.gov/node/1679101
‌
MAKScientific LLC SBIR Phase II Award, September 2016

A SBIR Phase II contract was awarded to MAKScientific LLC in September, 2016 for $1,292,438.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
2R44DK104636-02
Phase II
1,292,438
September 24, 2016
sbir.gov/node/1198925
‌
MAKScientific LLC SBIR Phase I Award, April 2015

A SBIR Phase I contract was awarded to MAKScientific LLC in April, 2015 for $232,633.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
1R43DK104636-01
Phase I
232,633
April 1, 2015
sbir.gov/node/1044181
‌
MAKScientific LLC SBIR Phase II Award,

A SBIR Phase II contract was awarded to MAKScientific LLC for $732,499.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
N44DA577424
Phase II
732,499
sbir.gov/content/novel-cb1-receptor-antagonist-phase-ii-0
‌
MAKScientific LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to MAKScientific LLC for $214,936.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
1R43DA036982-01A1
Phase I
214,936
sbir.gov/node/705473
‌
MAKScientific LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to MAKScientific LLC for $154,017.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
1R43DA018031-01
Phase I
154,017
sbir.gov/content/cb1-receptor-antagonists-drug-abuse-0
‌
MAKScientific LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to MAKScientific LLC for $130,066.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
1R43DA023737-01
Phase I
130,066
sbir.gov/content/new-drugs-enhance-endocannabinoid-responses-treating-excitotoxicity-0
‌
MAKScientific LLC SBIR Phase II Award,

A SBIR Phase II contract was awarded to MAKScientific LLC for $726,174.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
N44DA0900031
Phase II
726,174
sbir.gov/node/1065985
‌
MAKSCIENTIFIC, LLC SBIR Phase II Award,

A SBIR Phase II contract was awarded to MAKScientific LLC for $17,501.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
N44DA0577424C
Phase II
17,501
sbir.gov/node/1065325
‌
MAKScientific LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to MAKScientific LLC for $99,944.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
N43DA477423
Phase I
99,944
sbir.gov/content/novel-cb1-receptor-0
‌
MAKScientific LLC SBIR Phase I Award,

A SBIR Phase I contract was awarded to MAKScientific LLC for $119,000.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
N43DA0800010
Phase I
119,000
sbir.gov/content/novel-azetidine-cb1-antagonists-0
‌
MAKScientific LLC SBIR Phase II Award,

A SBIR Phase II contract was awarded to MAKScientific LLC for $1,005,890.0 USD from the U.S. Department of Health & Human Services.

‌
MAKScientific LLC
SBIR
2R44DA023737-02
Phase II
1,005,890
sbir.gov/content/new-drugs-enhance-endocannabinoid-responses-treating-excitotoxicity-phase-0
‌
MAKSCIENTIFIC SBIR Phase I Award, June 2023

A SBIR Phase I contract was awarded to MAKScientific LLC in June, 2023 for $320,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
MAKScientific LLC
National Institutes of Health
National Institutes of Health
SBIR
1R43DA057439-01
Phase I
320,000
June 1, 2023
sbir.gov/node/2506817
13 results
0 selected
13 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us